Dr Jess Pesner and Caleb Proctor, Revvity, explore the use of in vivo, in vitro models, and in silico models in the quest for new treatments for diseases of the eye. Within drug and device approval paths, regulated steps protect the well-being of the public and offer hope for those who may be battling a disease or a life event that may currently not be addressable. Agility and speed […]

To read this content in full, you need to login.

Not yet a DDW member? Join now for FREE – it takes less than 2 minutes!